A forum for researchers, students and applicants in the field of cyclodextrin technology
Niemann–Pick disease type C (NPC) is a recessive hereditary disease caused by mutation of the NPC1 or NPC2 gene. It is characterized by abnormality
The webinar of CycloLab “Getting the best out of cyclodextrins” was held on Apr.15-16, 2021. Out of >500 registrations over
Niemann-Pick disease type C (NPC) is a lysosomal storage disorder with disrupted intracellular cholesterol trafficking. HP-β-CD is a cholesterol solubilizer
Carbon monoxide (CO) is a gaseous molecule known as the silent killer. It is widely believed that an increase in
The review of Braga et al. describes the various roles of cyclodextrins (CDs) in vaccines againstviruses and in antiviral therapeutics
100% of patients who completed the trial improved or remained stable, and 89% met the efficacy outcome measure of improvement
A webinar organized by CycloLab will be held on April 15-16, 2021. Participation at the event is provided free of charge
Water-soluble seven hexylimidazolium modified amphiphilic cyclodextrin (AMCD) selectively combined with ATP to form a stable 1 : 1 inclusion complex
In May, 2020, CycloLab announced a collaboration, where University of California, Berkeley, Excivion and CycloLab teamed-up to evaluate the antiviral
Photo-crosslinkable polyrotaxanes (PRXs) via riboflavins (RBFs) were designed for anchoring to biological tissues. In particular, PRXs with amino groups, in
